NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Texas lawmakers are eyeing clinical trial for ibogaine as President Trump signed an executive order to speed up research into ...
The recent federal action directing the FDA to accelerate the review of psychedelic therapies marks a major shift in the ...
Clinical trials using psychedelic drugs could soon take place with the help of Louisiana’s Department of Health under ...
The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.
President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into ibogaine and other ...
Texas is moving forward with research into ibogaine, a psychedelic drug that some hope could help treat addiction, trauma and ...
The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what ...
President Trump has signed an executive order to fast-track psychedelic research and FDA approval, sparking debate among ...
U.S. President Donald Trump this week signed an executive order directing health regulators to speed reviews of psychedelic ...
Washington state, with its routine rainfall and mild temperatures, provides the perfect environment for mushroom growth, including psychedelic mushrooms. Psilocybin is a psychedelic compound found in ...